Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation

A growing body of literature suggests that most chronic autoimmune diseases are associated with inappropriate inflammation mediated by Toll-like receptor (TLR) 3, TLR7/8, or TLR9. Therefore, research into blocking TLR activation to treat these disorders has become a hot topic. Here, we report the im...

Full description

Saved in:
Bibliographic Details
Main Authors: Wancheng Liu, Xuejiao Yang, Ning Wang, Shijun Fan, Yuanfeng Zhu, Xinchuan Zheng, Yan Li
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2017/6541729
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564973899874304
author Wancheng Liu
Xuejiao Yang
Ning Wang
Shijun Fan
Yuanfeng Zhu
Xinchuan Zheng
Yan Li
author_facet Wancheng Liu
Xuejiao Yang
Ning Wang
Shijun Fan
Yuanfeng Zhu
Xinchuan Zheng
Yan Li
author_sort Wancheng Liu
collection DOAJ
description A growing body of literature suggests that most chronic autoimmune diseases are associated with inappropriate inflammation mediated by Toll-like receptor (TLR) 3, TLR7/8, or TLR9. Therefore, research into blocking TLR activation to treat these disorders has become a hot topic. Here, we report the immunomodulatory properties of a nonstimulatory CpG-containing oligodeoxynucleotide (CpG-ODN), CpG-c41, which had previously only been known as a TLR9 antagonist. In this study, we found that both in vitro and in vivo CpG-c41 decreased levels of various proinflammatory factors that were induced by single activation or coactivation of intracellular TLRs, but not membrane-bound TLRs, no matter what downstream signal pathways the TLRs depend on. Moreover, CpG-c41 attenuated excessive inflammation in the imiquimod-induced psoriasis-like mouse model of skin inflammation by suppressing immune cell infiltration and release of inflammatory factors. We also found evidence that the immunosuppressive effects of CpG-c41 on other intracellular TLRs are mediated by a TLR9-independent mechanism. These results suggest that CpG-c41 acts as an upstream of signaling cascades, perhaps on the processes of ligand internalization and transfer. Taken together, these results suggest that CpG-c41 disrupts various aspects of intracellular TLR activation and provides a deeper insight into the regulation of innate immunity.
format Article
id doaj-art-8693eba6758c47b6a1a0b18a9f571c8a
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-8693eba6758c47b6a1a0b18a9f571c8a2025-02-03T01:09:45ZengWileyMediators of Inflammation0962-93511466-18612017-01-01201710.1155/2017/65417296541729Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated InflammationWancheng Liu0Xuejiao Yang1Ning Wang2Shijun Fan3Yuanfeng Zhu4Xinchuan Zheng5Yan Li6Medical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaMedical Research Center, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaA growing body of literature suggests that most chronic autoimmune diseases are associated with inappropriate inflammation mediated by Toll-like receptor (TLR) 3, TLR7/8, or TLR9. Therefore, research into blocking TLR activation to treat these disorders has become a hot topic. Here, we report the immunomodulatory properties of a nonstimulatory CpG-containing oligodeoxynucleotide (CpG-ODN), CpG-c41, which had previously only been known as a TLR9 antagonist. In this study, we found that both in vitro and in vivo CpG-c41 decreased levels of various proinflammatory factors that were induced by single activation or coactivation of intracellular TLRs, but not membrane-bound TLRs, no matter what downstream signal pathways the TLRs depend on. Moreover, CpG-c41 attenuated excessive inflammation in the imiquimod-induced psoriasis-like mouse model of skin inflammation by suppressing immune cell infiltration and release of inflammatory factors. We also found evidence that the immunosuppressive effects of CpG-c41 on other intracellular TLRs are mediated by a TLR9-independent mechanism. These results suggest that CpG-c41 acts as an upstream of signaling cascades, perhaps on the processes of ligand internalization and transfer. Taken together, these results suggest that CpG-c41 disrupts various aspects of intracellular TLR activation and provides a deeper insight into the regulation of innate immunity.http://dx.doi.org/10.1155/2017/6541729
spellingShingle Wancheng Liu
Xuejiao Yang
Ning Wang
Shijun Fan
Yuanfeng Zhu
Xinchuan Zheng
Yan Li
Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
Mediators of Inflammation
title Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
title_full Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
title_fullStr Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
title_full_unstemmed Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
title_short Multiple Immunosuppressive Effects of CpG-c41 on Intracellular TLR-Mediated Inflammation
title_sort multiple immunosuppressive effects of cpg c41 on intracellular tlr mediated inflammation
url http://dx.doi.org/10.1155/2017/6541729
work_keys_str_mv AT wanchengliu multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT xuejiaoyang multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT ningwang multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT shijunfan multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT yuanfengzhu multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT xinchuanzheng multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation
AT yanli multipleimmunosuppressiveeffectsofcpgc41onintracellulartlrmediatedinflammation